Research news

A research team involving UCLH clinicians has found a way to reduce the side effects of treatment for a disorder of the adrenal glands.

UCLH has recruited the first patient in Europe for an early phase trial of a potential new medicine for patients that have a specific sub-type of multiple myeloma (MM), a type of bone marrow cancer.

A drug commonly used to treat cystic fibrosis improved outcomes for patients with severe COVID-19 pneumonia and could be used to treat other respiratory infections, according to clinical trial results from researchers at UCLH, UCL and the Francis Crick Institute.

A clinical trial at UCLH will investigate whether a new type of immune therapy can prevent colorectal cancer from returning.

Over 150 people visited a highly successful health and research engagement event in Camden which engaged the local community in healthcare innovation, research, and how to stay healthy.